Meeting
2013 Breast Cancer Symposium
The accuracy of preoperative U.S.-guided vacuum-assisted breast biopsy (VABB) in determining ER, PgR, HER2, and Ki67 status in early breast cancer.
Authors
Keitaro Kamei
Department of Surgery, Ogaki Municipal Hospital, Gifu, Japan
Keitaro Kamei , Takashi Fujita , Toshikazu Ito , Hiroshi Yagata , Minoru Ono , Ryoji Watanabe , Naoya Gomi , Kiyoshi Onishi , Naomi Sakamoto , Hideyuki Hashimoto , Tetsuya Taguchi , Takahiro Nakayama
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A
Track
Local/Regional Therapy,Risk Assessment, Prevention, Detection, and Screening
Sub Track
High Risk
Citation
J Clin Oncol 31, 2013 (suppl 26; abstr 37)
DOI
10.1200/jco.2013.31.26_suppl.37
Abstract #
37
Poster Bd #
C19
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
The proliferation biomarker SPAG5 expression in HER2 low and HER2 overexpression early breast cancer (BC) predicting tumour response to neoadjuvant chemotherapy (NACT) with and without trastuzumab.
First Author: Tarek Mohamed Ahmed Abdel-Fatah
Poster
2011 Breast Cancer Symposium
Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer: Results from the GeparQuattro study (GBG 40).
First Author: G. Von Minckwitz
Poster
2023 ASCO Annual Meeting
Evolution of HER2 scores after neoadjuvant systemic therapy in breast cancer.
First Author: Esther G Chong
Poster
2023 ASCO Annual Meeting
Clinical meaning of stromal tumor infiltrating lymphocytes (sTIL) in luminal early breast cancer.
First Author: Esmeralda García-Torralba